KAPA · Company research

Kairos Pharma, Ltd. (KAPA): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Unusual Volume Stocks Today: MI, BIYA, SMXT Gain; VCIG and KAPA Slide - ChartMillUnusual Volume Stocks Today: MI, BIYA, SMXT Gain; VCIG and KAPA Slide ChartMillView source ↗ChartMillOct 8, 2026neutral00.6
Why Is Kairos Pharma Stock Falling Today? - Kairos Pharma (AMEX:KAPA) - BenzingaWhy Is Kairos Pharma Stock Falling Today? - Kairos Pharma (AMEX:KAPA) BenzingaView source ↗BenzingaOct 6, 2026neutral00.6
Kairos Pharma (KAPA) Holds Steady at $1.56 as Traders Watch $1.64 Resistance - Rating Change - https://www.siam.in/Kairos Pharma (KAPA) Holds Steady at $1.56 as Traders Watch $1.64 Resistance - Rating Change https://www.siam.in/View source ↗https://www.siam.in/Oct 3, 2026neutral00.6
Kairos Pharma, Ltd. (KAPA) Stock Price & News - SyfeKairos Pharma, Ltd. (KAPA) Stock Price & News SyfeView source ↗SyfeSep 24, 2026neutral00.6
A cancer drug candidate designed to boost immune cells against tumors will be presented by Kairos Pharma. - Stock TitanA cancer drug candidate designed to boost immune cells against tumors will be presented by Kairos Pharma. Stock TitanView source ↗Stock TitanSep 23, 2026neutral00.6
Kairos (KAPA) Soars +3.47% Past $1.88 — New Highs Ahead? 2026-09-22 - Small Cap Breakouts - dars.gov.etKairos (KAPA) Soars +3.47% Past $1.88 — New Highs Ahead? 2026-09-22 - Small Cap Breakouts dars.gov.etView source ↗dars.gov.etSep 22, 2026neutral00.6
Kairos Pharma (KAPA) to present clinical update at H.C. Wainwright investor conference - Stock TitanKairos Pharma (KAPA) to present clinical update at H.C. Wainwright investor conference Stock TitanView source ↗Stock TitanSep 14, 2026neutral00.6
Kairos Pharma to conduct 1-for-7 reverse stock split - Investing.comKairos Pharma to conduct 1-for-7 reverse stock split Investing.comView source ↗Investing.comAug 21, 2026neutral00.6
Kairos Pharma (KAPA) Stock Surges Over 22% After Hours: Why is it Moving? - BenzingaKairos Pharma (KAPA) Stock Surges Over 22% After Hours: Why is it Moving? BenzingaView source ↗BenzingaJul 16, 2026neutral00.6
CEO.CA's Inside the Boardroom: Kairos Pharma Might Change Cancer Treatment Forever - TradingViewCEO.CA's Inside the Boardroom: Kairos Pharma Might Change Cancer Treatment Forever TradingViewView source ↗TradingViewJul 15, 2026neutral00.6
All You Need to Know About Kairos Pharma, Ltd. (KAPA) Rating Upgrade to Buy - Yahoo FinanceAll You Need to Know About Kairos Pharma, Ltd. (KAPA) Rating Upgrade to Buy Yahoo FinanceView source ↗Yahoo FinanceJul 2, 2026neutral00.6
Should I buy Kairos Pharma, Ltd. (KAPA) - Zacks Investment ResearchShould I buy Kairos Pharma, Ltd. (KAPA) Zacks Investment ResearchView source ↗Zacks Investment ResearchJul 2, 2026neutral00.6
KAPA - FinvizKAPA FinvizView source ↗FinvizMay 28, 2026neutral00.6
Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB) - The Globe and MailAnalysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB) The Globe and MailView source ↗The Globe and MailMay 15, 2026neutral00.6
Kairos Pharma (KAPA) Institutional Ownership 2026 - MarketBeatKairos Pharma (KAPA) Institutional Ownership 2026 MarketBeatView source ↗MarketBeatFeb 18, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJun 13, 2024neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.